SCHEMBL3693807

SCHEMBL3693807

C[Si](Cl)(Cl)C=C[Si](C)(Cl)Cl

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19136052 1.00 ALDH1A1 (0.46) ALDH1A1
SCHEMBL3693804 1.00 ALDH1A1 (0.46) ALDH1A1
SCHEMBL7764547 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL7764552 0.88 ALDH1A1 (0.36) ALDH1A1
SCHEMBL1493113 0.79
SCHEMBL6054074 0.70
SCHEMBL7767449 0.70 ALDH1A1 (0.46) ALDH1A1
SCHEMBL7767453 0.70 ALDH1A1 (0.46) ALDH1A1
SCHEMBL59211 0.67
SCHEMBL10404218 0.65 ALDH1A1 (0.71) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760842-B2 Composition comprising block copolymer, and method for producing siliceous film using the same MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
EP-3953416-B1 COMPOSITION COMPRISING BLOCK COPOLYMER, AND METHOD FOR PRODUCING SILICEOUS FILM USING THE SAME MERCK PATENT GMBH (DE) 2022-10-26 EP disclosed
US-20220204704-A1 COMPOSITION COMPRISING BLOCK COPOLYMER, AND METHOD FOR PRODUCING SILICEOUS FILM USING THE SAME MERCK PATENT GMBH (DE) 2022-06-30 US disclosed
EP-2872545-B1 PROCESS FOR PRODUCING ORGANOPOLYSILOXANES WACKER CHEMIE AG (DE) 2016-09-07 EP disclosed
US-9175138-B2 Method for producing organopolysiloxanes WACKER CHEMIE AG (DE) 2015-11-03 US disclosed
US-20150166732-A1 METHOD FOR PRODUCING ORGANOPOLYSILOXANES WACKER CHEMIE AG (DE) 2015-06-18 US disclosed
EP-2452943-B1 Method for producing alkoxy-substituted 1,2-Bis-Silyl-Ethanes WACKER CHEMIE AG (DE) 2013-07-10 EP disclosed
US-20120123143-A1 METHOD FOR PRODUCING ALKOXY-SUBSTITUTED 1,2-BISSILYLETHANES WACKER CHEMIE AG (DE) 2012-05-17 US disclosed
EP-2452943-A1 Method for producing alkoxy-substituted 1,2-Bis-Silyl-Ethanes Wacker Chemie AG (DE) 2012-05-16 EP disclosed
EP-1103556-B1 Process for preparing halogenated 1,2-disilaethane compounds WACKER CHEMIE GMBH (DE) 2001-11-14 EP disclosed
US-6271406-B1 HYDROGENATING HALOGENATED 1,2-DISILAETHYLENES WACKER-CHEMIE GMBH (DE) 2001-08-07 US disclosed
EP-1103556-A1 Process for preparing halogenated 1,2-disilaethane compounds Wacker-Chemie GmbH (DE) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123143-A1 METHOD FOR PRODUCING ALKOXY-SUBSTITUTED 1,2-BISSILYLETHANES NR2C2, NR3C2, NR5A1 ALDH1A1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.